etodolac and diclofenac

etodolac has been researched along with diclofenac in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19904 (9.30)18.7374
1990's13 (30.23)18.2507
2000's11 (25.58)29.6817
2010's13 (30.23)24.3611
2020's2 (4.65)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Cihlar, T; Ho, ES; Mulato, AS1
Beroza, P; Cai, D; Damodaran, K; Gomez, RF; Hsu, N; Keck, JG; Laborde, E; Lum, RT; Macke, TJ; Martin, G; Schow, SR; Simon, RJ; Villar, HO; Wick, MM1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Kumar, M; Sinha, VR; Thareja, S1
Furukawa, T; Hosoya, K; Kadono, K; Moriguchi, H; Nakamori, F; Naritomi, Y; Teramura, T; Terashita, S; Tetsuka, K; Yamano, K1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
DeRose, EF; Duff, MR; Gabel, SA; Howell, EE; Krahn, JM; London, RE; Pedersen, LC1
de Pouvourville, G1
Khan, FM; Williams, PI1
Mizraji, M1
Pena, M1
Platt, PN1
Briancon, D1
Karbowski, A1
Bazzichi, L; Ciompi, ML; Marotta, G; Puccetti, L; Remorini, E1
Dainaka, J; Hashii, H; Inoue, K; Kimura, K; Motonaga, A; Nishimura, T; Ueda, F; Yamate, K1
Bacon, PA1
Franchimont, P; Reginster, JY1
Porzio, F1
Bacon, P1
Bijlsma, JW; Lim, HG; Lonauer, G; Tisscher, JR1
Caruso, FS; Frenk, H; Lu, J; Mao, J; Mayer, DJ; Price, DD1
Campbell, F; Lipscomb, GR; Rees, WD1
El Kousy, NM1
Huskisson, EC1
Browning, RA; Burgess, FW1
Berdat, PA; Carrel, TP; Curatolo, M; Eigenmann, V; Immer, FF; Immer-Bansi, AS; Trachsel, N1
Inoue, N; Matsui, M; Tachibana, M; Ukai, Y; Yano, J; Yoshida, E1
Hsu, PN; Liang, TH1
Alem, MA; Douglas, LJ1
Banerjee, S; Phaujdar, S; Santra, G; Sarkar, RN; Siddhanta, S1
Chandurkar, N; Desai, Y; Gupta, A; Kumar S, H; Pareek, A; Sirsikar, A; Swamy, A1
Banno, K; Inoue, N; Ito, S; Kotera, T; Kyoi, T; Nakamura, A; Nogawa, M; Sasagawa, T; Tajima, K; Takahashi, Y; Ueda, M; Yamashita, Y1
Haruma, K; Hata, J; Iida, A; Imamura, H; Manabe, N1
Akbulut, N; Atakan, C; Çölok, G; Üstüner, E1
Kanbayashi, Y; Konishi, H1
Haraguchi, T; Kojima, H; Li, D; Nakamura, S; Shiraishi, S; Uchida, T; Yoshida, M1
Pedersen, L; Schmidt, M; Sørensen, HT1

Reviews

6 review(s) available for etodolac and diclofenac

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Etodolac: analgesic effects in musculoskeletal and postoperative pain.
    Rheumatology international, 1990, Volume: 10 Suppl

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Aspirin; Athletic Injuries; Back Pain; Bursitis; Diclofenac; Dose-Response Relationship, Drug; Etodolac; Humans; Indoleacetic Acids; Musculoskeletal System; Naproxen; Pain, Postoperative; Piroxicam; Tendinopathy

1990
A global safety evaluation of etodolac.
    Clinical rheumatology, 1989, Volume: 8 Suppl 1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Male; Middle Aged; Naproxen; Osteoarthritis; Piroxicam

1989
Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    European journal of rheumatology and inflammation, 1993, Volume: 12, Issue:4

    Topics: Acute Disease; Adult; beta-Cyclodextrins; Controlled Clinical Trials as Topic; Cyclodextrins; Diclofenac; Dipyrone; Drug Combinations; Etodolac; Humans; Ketoprofen; Middle Aged; Pain; Piroxicam; Rheumatic Diseases

1993
Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Rheumatology international, 1993, Volume: 13, Issue:2 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis; Pain; Piroxicam; Random Allocation

1993
Nimesulide, a balanced drug for the treatment of osteoarthritis.
    Clinical and experimental rheumatology, 2001, Volume: 19, Issue:1 Suppl 22

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Etodolac; Humans; Naproxen; Osteoarthritis; Stomach Diseases; Sulfonamides; Treatment Outcome

2001

Trials

14 trial(s) available for etodolac and diclofenac

ArticleYear
Double-blind comparison of etodolac SR and diclofenac SR in the treatment of patients with degenerative joint disease of the knee.
    Current medical research and opinion, 1992, Volume: 13, Issue:1

    Topics: Aged; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Etodolac; Female; Hematocrit; Hemoglobins; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis; Treatment Outcome

1992
Clinical response to etodolac in the management of pain.
    European journal of rheumatology and inflammation, 1990, Volume: 10, Issue:1

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Athletic Injuries; Bursitis; Diclofenac; Etodolac; Female; Gout; Humans; Indoleacetic Acids; Male; Naproxen; Pain, Postoperative; Palliative Care; Tendinopathy

1990
Etodolac: analgesic effects in musculoskeletal and postoperative pain.
    Rheumatology international, 1990, Volume: 10 Suppl

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Aspirin; Athletic Injuries; Back Pain; Bursitis; Diclofenac; Dose-Response Relationship, Drug; Etodolac; Humans; Indoleacetic Acids; Musculoskeletal System; Naproxen; Pain, Postoperative; Piroxicam; Tendinopathy

1990
Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee.
    Clinical rheumatology, 1989, Volume: 8 Suppl 1

    Topics: Activities of Daily Living; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Knee Joint; Male; Middle Aged; Multicenter Studies as Topic; Naproxen; Osteoarthritis; Piroxicam; Random Allocation

1989
International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.
    Clinical rheumatology, 1989, Volume: 8 Suppl 1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Male; Middle Aged; Multicenter Studies as Topic; Naproxen; Piroxicam; Prospective Studies; Random Allocation

1989
A global safety evaluation of etodolac.
    Clinical rheumatology, 1989, Volume: 8 Suppl 1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Male; Middle Aged; Naproxen; Osteoarthritis; Piroxicam

1989
Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
    International journal of clinical pharmacology research, 1989, Volume: 9, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Sedimentation; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Etodolac; Female; Humans; Indoleacetic Acids; Male; Middle Aged; Random Allocation

1989
Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Rheumatology international, 1993, Volume: 13, Issue:2 Suppl

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Etodolac; Global Health; Hip Joint; Humans; Indomethacin; Knee Joint; Middle Aged; Naproxen; Osteoarthritis; Pain; Piroxicam; Time Factors

1993
Double-blind comparison of etodolac and diclofenac in patients with rheumatoid arthritis.
    Current medical research and opinion, 1993, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Diclofenac; Etodolac; Female; Humans; Male; Middle Aged; Pain Measurement; Range of Motion, Articular

1993
Pain treatment with a COX-2 inhibitor after coronary artery bypass operation: a randomized trial.
    The Annals of thoracic surgery, 2003, Volume: 75, Issue:2

    Topics: Aged; Analgesics, Opioid; Coronary Artery Bypass; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Female; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Tramadol; Urea

2003
Double-blind, randomised, comparative trial of etodolac SR versus diclofenac in the treatment of osteoarthritis of the knee.
    Current medical research and opinion, 2003, Volume: 19, Issue:4

    Topics: Abdominal Pain; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Etodolac; Female; Gastrointestinal Hemorrhage; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis

2003
Comparative evaluation of efficacy and safety of etodolac and diclofenac sodium injection in patients with postoperative orthopedic pain.
    Current medical research and opinion, 2011, Volume: 27, Issue:11

    Topics: Adolescent; Adult; Aged; Cyclooxygenase Inhibitors; Diclofenac; Drug Administration Schedule; Etodolac; Female; Humans; Injections; Male; Middle Aged; Orthopedics; Pain Measurement; Pain, Postoperative; Young Adult

2011
Evaluating the effects of diclofenac sodium and etodolac on renal hemodynamics with contrast-enhanced ultrasonography: a pilot study.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Etodolac; Female; Hemodynamics; Humans; Kidney; Male; Renal Circulation; Ultrasonography

2013
Comparison of the effect of naproxen, etodolac and diclofenac on postoperative sequels following third molar surgery: a randomised, double-blind, crossover study.
    Medicina oral, patologia oral y cirugia bucal, 2014, Mar-01, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac; Double-Blind Method; Edema; Etodolac; Female; Humans; Male; Molar, Third; Naproxen; Pain, Postoperative; Tooth Extraction; Tooth, Impacted; Trismus; Young Adult

2014

Other Studies

25 other study(ies) available for etodolac and diclofenac

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 295, Issue:1

    Topics: Adenine; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Biological Transport; Carrier Proteins; Humans; Kidney; Organophosphonates; Structure-Activity Relationship

2000
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
    Journal of medicinal chemistry, 2004, Sep-23, Volume: 47, Issue:20

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Combinatorial Chemistry Techniques; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Design; Drug Evaluation, Preclinical; Ibuprofen; Inhibitory Concentration 50; Isoenzymes; Models, Molecular; Models, Theoretical; Molecular Structure; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Quantitative Structure-Activity Relationship

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:4

    Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Self-organizing molecular field analysis of NSAIDs: assessment of pharmacokinetic and physicochemical properties using 3D-QSPkR approach.
    European journal of medicinal chemistry, 2012, Volume: 53

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Computational Biology; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Quantitative Structure-Activity Relationship

2012
Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9

    Topics: Administration, Oral; Biotransformation; Cell Membrane Permeability; Cytochrome P-450 Enzyme System; Glucuronides; Glucuronosyltransferase; Humans; Intestinal Absorption; Intestines; Isoenzymes; Kinetics; Metabolic Clearance Rate; Microsomes; Models, Biological; Pharmaceutical Preparations; Recombinant Proteins; Substrate Specificity

2012
The Structural Basis for Nonsteroidal Anti-Inflammatory Drug Inhibition of Human Dihydrofolate Reductase.
    Journal of medicinal chemistry, 2020, 08-13, Volume: 63, Issue:15

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Crystallography, X-Ray; Drug Design; Folic Acid; Folic Acid Antagonists; Humans; Models, Molecular; Tetrahydrofolate Dehydrogenase

2020
The economic consequences of NSAID-induced gastropathy: the French context.
    Scandinavian journal of rheumatology. Supplement, 1992, Volume: 96

    Topics: Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Cost of Illness; Diclofenac; Duodenal Ulcer; Economics, Hospital; Etodolac; France; Gastrointestinal Diseases; Humans; Ketoprofen; Naproxen; National Health Programs; Piroxicam; Rheumatic Diseases; Sulindac

1992
Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 51, Issue:6

    Topics: Animals; Aspirin; Bradykinin; Bromelains; Cartilage, Articular; Cell Line; Concanavalin A; Depression, Chemical; Diclofenac; Dinoprostone; Dogs; Etodolac; Gastric Mucosa; Guinea Pigs; Indomethacin; Interleukin-1; Ketoprofen; Kidney; Naproxen; Oxygen; Pain; Piroxicam; Rabbits; Rats

1994
Safety profile of etodolac in the elderly population.
    European journal of rheumatology and inflammation, 1994, Volume: 14, Issue:1

    Topics: Age Factors; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Delayed-Action Preparations; Diclofenac; Dose-Response Relationship, Drug; Drug Tolerance; Etodolac; Humans; Middle Aged; Osteoarthritis; Piroxicam

1994
Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats.
    Pain, 1996, Volume: 68, Issue:1

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Behavior, Animal; Dextromethorphan; Diclofenac; Drug Interactions; Drug Therapy, Combination; Etodolac; Ibuprofen; Injections, Intraperitoneal; Male; Naproxen; Pain; Piroxicam; Rats; Rats, Sprague-Dawley

1996
The influence of age, gender, Helicobacter pylori and smoking on gastric mucosal adaptation to non-steroidal anti-inflammatory drugs.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tolerance; Etodolac; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Naproxen; Retrospective Studies; Sex Factors; Smoking; Stomach Diseases

1997
Spectrophotometric and spectrofluorimetric determination of etodolac and aceclofenac.
    Journal of pharmaceutical and biomedical analysis, 1999, Volume: 20, Issue:1-2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Capsules; Chromatography, High Pressure Liquid; Colorimetry; Diclofenac; Etodolac; Indicators and Reagents; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tablets

1999
Nonsteroidal anti-inflammatory drugs for perioperative pain control.
    Medicine and health, Rhode Island, 2001, Volume: 84, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Humans; Ibuprofen; Indomethacin; Ketorolac; Lactones; Nabumetone; Naproxen; Pain, Postoperative; Piroxicam; Pyrazoles; Sulfonamides; Sulfones; Time Factors

2001
Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Pharmacology, 2003, Volume: 68, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Diclofenac; Edema; Etodolac; Gastric Mucosa; Indomethacin; Male; Meloxicam; Mice; Peptic Ulcer; Rats; Species Specificity; Thiazines; Thiazoles

2003
Prostaglandin production during growth of Candida albicans biofilms.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 11

    Topics: Aspirin; Biofilms; Candida albicans; Cyclooxygenase Inhibitors; Diclofenac; Etodolac; Microscopy, Electron, Scanning; Morphogenesis; Prostaglandins; Signal Transduction; Virulence Factors

2005
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Singapore medical journal, 2010, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Cyclooxygenase 2 Inhibitors; Diclofenac; Diphosphonates; Etodolac; Female; Health Status Indicators; Humans; Indomethacin; Male; Pamidronate; Prospective Studies; Spondylitis, Ankylosing; Treatment Failure; Tumor Necrosis Factor-alpha; Young Adult

2010
Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:1

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Drug Interactions; Duloxetine Hydrochloride; Etodolac; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mexiletine; Mice; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Thiophenes; Tissue Distribution

2012
Predictive Factors for NSAIDs-related Gastrointestinal Toxicity: Can COX-2 Selective Inhibtor Prevent it?.
    Hepato-gastroenterology, 2015, Volume: 62, Issue:140

    Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Aspirin; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Duodenal Diseases; Duodenal Ulcer; Endoscopy, Digestive System; Etodolac; Female; Humans; Logistic Models; Male; Middle Aged; Phenylpropionates; Protective Factors; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Ulcer

2015
Taste-Masking Effect of Chlorogenic Acid (CGA) on Bitter Drugs Evaluated by Taste Sensor and Surface Plasmon Resonance on the Basis of CGA-Drug Interactions.
    Chemical & pharmaceutical bulletin, 2017, Volume: 65, Issue:2

    Topics: Alanine; Amlodipine; Chlorogenic Acid; Diclofenac; Diphenhydramine; Donepezil; Drug Interactions; Etodolac; Indans; Piperidines; Quinolones; Surface Plasmon Resonance; Taste

2017
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials.
    Drug safety, 2022, Volume: 45, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Etodolac; Etoricoxib; Female; Heart Disease Risk Factors; Humans; Meloxicam; Risk Factors

2022